A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in ...

The Trump administration has cut around 100 employees, or roughly 10%, of the federal agency that oversees mental and ...

The company is planning a Phase 3 trial for the new formulation of lenacapavir, Stat reports. Other pharma and technology news is on microplastics and the spread of antibiotic-resistant superbugs; a ...

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

COVID-19 took the lives of more than one million Americans and nearly 116,000 Californians, according to the Centers for Disease Control and Prevention.

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people ...